Literature DB >> 8508322

Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo.

A Rami1, J Krieglstein.   

Abstract

The calpains are calcium-dependent intracellular proteases that are activated in a number of pathogenic conditions. We tested the capacities of protease inhibitors, calpain inhibitor I and leupeptin, to protect against the neuronal degeneration caused by cytotoxic hypoxia or transient global cerebral ischemia. Primary neuronal cultures were prepared from embryonic chick telencephalon, and cytotoxic hypoxia was induced by adding 1 mM NaCN to the culture medium for 30 min. Global ischemia was induced in rats by clamping both carotid arteries and lowering the arterial blood pressure to 40 mmHg for 10 min. Both calpain inhibitor I and leupeptin protected neurons against ischemic and hypoxic damage. Neuroprotection was indicated by increased cell viability and protein content in the cultures, and fewer damaged neurons in the hippocampal CA1-subfield. Thus, blockade of proteolysis can protect neurons against cytotoxic and ischemic damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508322     DOI: 10.1016/0006-8993(93)90856-i

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.

Authors:  Susan B Glantz; Carol D Cianci; Rathna Iyer; Deepti Pradhan; Kevin K W Wang; Jon S Morrow
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

3.  RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia.

Authors:  Matthew B Bevers; Lori P Ingleton; Dongfang Che; Jeffrey T Cole; Luchuan Li; Tong Da; Catherine M Kopil; Akiva S Cohen; Robert W Neumar
Journal:  Exp Neurol       Date:  2010-03-15       Impact factor: 5.330

Review 4.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

5.  Neuroprotection with delayed calpain inhibition after transient forebrain ischemia.

Authors:  James R Frederick; Zhaoming Chen; Matthew B Bevers; Lori P Ingleton; Marek Ma; Robert W Neumar
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

6.  Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; H Mota-Filipe; T Centorrino; M L Terranova; A Ciccolo; D Britti; A P Caputi; C Thiemermann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity.

Authors:  Matthew B Bevers; Eric Lawrence; Margaret Maronski; Neasa Starr; Michael Amesquita; Robert W Neumar
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

8.  Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.

Authors:  Ming Sun; Yumei Zhao; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-12-21       Impact factor: 5.046

9.  Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis.

Authors:  Mien V Hoang; Janice A Nagy; Joan E B Fox; Donald R Senger
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

10.  Contribution of NMDA and non-NMDA receptors to in vivo glutamate-induced calpain activation in the rat striatum. Relation to neuronal damage.

Authors:  Perla Del Río; Teresa Montiel; Lourdes Massieu
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.